A neonate with congenital amegakaryocytic thrombocytopenia associated with a chromosomal microdeletion at 21q22.11 including the gene RUNX1

J Perinatol. 2013 Mar;33(3):242-4. doi: 10.1038/jp.2012.53.

Abstract

We observed a neonate who had severe thrombocytopenia wherein evaluations for neonatal immune-mediated thrombocytopenia and congenital infections were negative, and the marrow findings were consistent with congenital amegakaryocytic thrombocytopenia (CAMT). A genomic microarray identified a microdeletion at 21q22.11 including the gene RUNX1. Two somewhat similar cases were recently reported, but with multiple congenital anomalies that are not present in our case. We propose that a 21q22 deletion resulting in RUNX1 haploinsufficiency can produce a phenotype similar to CAMT with various associated anomalies depending on which adjacent genes are absent or disrupted.

Publication types

  • Case Reports

MeSH terms

  • Chromosome Deletion*
  • Chromosomes, Human, Pair 22
  • Congenital Bone Marrow Failure Syndromes
  • Core Binding Factor Alpha 2 Subunit / genetics*
  • Developmental Disabilities / complications
  • Developmental Disabilities / genetics
  • Humans
  • Infant, Newborn
  • Intubation, Gastrointestinal
  • Phenotype
  • Protein Array Analysis
  • Thrombocytopenia / complications
  • Thrombocytopenia / genetics*

Substances

  • Core Binding Factor Alpha 2 Subunit
  • RUNX1 protein, human

Supplementary concepts

  • Chromosome 22, microdeletion 22 q11
  • Congenital amegakaryocytic thrombocytopenia